Daiwa Securities Group Inc. - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$14
-12.5%
6510.0%0.00%
Q2 2023$16
+33.3%
6510.0%0.00%
Q1 2023$12
+20.0%
6510.0%0.00%
Q4 2022$10
-99.9%
651
+38.8%
0.00%
Q3 2022$8,000
+14.3%
4690.0%0.00%
Q2 2022$7,000
-36.4%
4690.0%0.00%
Q1 2022$11,0000.0%4690.0%0.00%
Q4 2021$11,000
+22.2%
469
-14.7%
0.00%
Q3 2021$9,000
+12.5%
550
+73.5%
0.00%
Q2 2021$8,0000.0%3170.0%0.00%
Q1 2021$8,000
-50.0%
317
+6.0%
0.00%
Q4 2020$16,000
-56.8%
299
-66.4%
0.00%
Q3 2020$37,0000.0%889
+2.3%
0.00%
-100.0%
Q2 2020$37,0000.0%8690.0%0.00%
Q1 2020$37,0000.0%8690.0%0.00%
Q4 2019$37,000
+12.1%
869
-5.0%
0.00%
Q3 2019$33,000
+37.5%
9150.0%0.00%
Q2 2019$24,000
-4.0%
9150.0%0.00%
Q1 2019$25,000
-96.0%
915
-97.6%
0.00%
-100.0%
Q4 2018$625,000
-28.2%
38,688
-7.7%
0.01%
-14.3%
Q3 2018$870,0000.0%41,901
-26.5%
0.01%0.0%
Q2 2018$870,000
-47.2%
57,006
-22.2%
0.01%
-46.2%
Q1 2018$1,647,000
-23.9%
73,295
+2.0%
0.01%
-13.3%
Q4 2017$2,163,00071,8480.02%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Finepoint Capital LP 556,553$11,598,5655.78%
Baker Brothers Advisors 42,864,612$893,298,5145.15%
RTW INVESTMENTS, LP 11,576,537$241,255,0315.09%
Palo Alto Investors LP 2,405,793$50,136,7264.74%
Birchview Capital, LP 240,400$5,009,9364.26%
EcoR1 Capital, LLC 5,991,479$124,862,4224.21%
EMERALD ADVISERS, LLC 1,681,052$35,033,1241.70%
EMERALD MUTUAL FUND ADVISERS TRUST 1,303,988$27,175,1101.64%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 179,702$3,739,5991.26%
SECTOR GAMMA AS 179,785$3,746,7190.96%
View complete list of ACADIA PHARMACEUTICALS INC shareholders